| Quen Joshua Cheng, | |
|
200 Med Plaza Suite 365, 420, 120, Los Angeles, CA 90095 | |
| (310) 206-7663 | |
| Not Available |
| Full Name | Quen Joshua Cheng |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 12 Years |
| Location | 200 Med Plaza Suite 365, 420, 120, Los Angeles, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194091298 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ronald Reagan Ucla Medical Center | Los angeles, CA | Hospital |
| Santa Monica - Ucla Med Ctr & Orthopaedic Hospital | Santa monica, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Regents Of The University Of California | 1355248584 | 1177 |
News Archive
DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the launch of the Company's new web site. Unveiled at the Annual Shareholder Meeting, the interactive web site is a continuation of DATATRAK's singular vision for product and service delivery - DATATRAK ONE(TM).
Ahead of Wednesday's mark-up of the FY 2011 state and foreign ops appropriations bill, Foreign Policy's "The Cable" blog examines recent comments made by House Foreign Operations Subcommittee Chairwoman Nita Lowey (D-N.Y.) in which she "promised … to remove all the Afghanistan foreign operations and aid money from next year's funding unless she can be assured none of the funds are being wasted due to corruption in the Afghanistan government."
TriLink BioTechnologies, Inc. was recently awarded a Phase I SBIR Grant of approximately $100,000 by the National Institutes of Health to develop a Hot Start approach for Ligase Chain Reaction (LCR). Hot Start LCR will employ chemically modified ligation components containing thermolabile protecting groups to eliminate common performance problems seen in LCR, such as false-positive signals and non-specificity.
In today's troubled economy, saving money is a hot topic. No matter what gets cut from your budget, however, experts at The University of Texas M. D. Anderson Cancer Center believe that healthy choices to prevent cancer shouldn't be on the list.
Safe, in-person school during the COVID-19 pandemic requires research that involves community engagement in underserved or vulnerable areas of the United States, writes Alison Cernich, Ph.D., deputy director of NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and colleagues.
› Verified 5 days ago
| Entity Name | The Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235107566 PECOS PAC ID: 1355248584 Enrollment ID: O20031223000439 |
News Archive
DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the launch of the Company's new web site. Unveiled at the Annual Shareholder Meeting, the interactive web site is a continuation of DATATRAK's singular vision for product and service delivery - DATATRAK ONE(TM).
Ahead of Wednesday's mark-up of the FY 2011 state and foreign ops appropriations bill, Foreign Policy's "The Cable" blog examines recent comments made by House Foreign Operations Subcommittee Chairwoman Nita Lowey (D-N.Y.) in which she "promised … to remove all the Afghanistan foreign operations and aid money from next year's funding unless she can be assured none of the funds are being wasted due to corruption in the Afghanistan government."
TriLink BioTechnologies, Inc. was recently awarded a Phase I SBIR Grant of approximately $100,000 by the National Institutes of Health to develop a Hot Start approach for Ligase Chain Reaction (LCR). Hot Start LCR will employ chemically modified ligation components containing thermolabile protecting groups to eliminate common performance problems seen in LCR, such as false-positive signals and non-specificity.
In today's troubled economy, saving money is a hot topic. No matter what gets cut from your budget, however, experts at The University of Texas M. D. Anderson Cancer Center believe that healthy choices to prevent cancer shouldn't be on the list.
Safe, in-person school during the COVID-19 pandemic requires research that involves community engagement in underserved or vulnerable areas of the United States, writes Alison Cernich, Ph.D., deputy director of NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and colleagues.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Quen Joshua Cheng, 5767 W Century Blvd Ste 400, Los Angeles, CA 90045-5631 Ph: (310) 301-8707 | Quen Joshua Cheng, 200 Med Plaza Suite 365, 420, 120, Los Angeles, CA 90095 Ph: (310) 206-7663 |
News Archive
DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the launch of the Company's new web site. Unveiled at the Annual Shareholder Meeting, the interactive web site is a continuation of DATATRAK's singular vision for product and service delivery - DATATRAK ONE(TM).
Ahead of Wednesday's mark-up of the FY 2011 state and foreign ops appropriations bill, Foreign Policy's "The Cable" blog examines recent comments made by House Foreign Operations Subcommittee Chairwoman Nita Lowey (D-N.Y.) in which she "promised … to remove all the Afghanistan foreign operations and aid money from next year's funding unless she can be assured none of the funds are being wasted due to corruption in the Afghanistan government."
TriLink BioTechnologies, Inc. was recently awarded a Phase I SBIR Grant of approximately $100,000 by the National Institutes of Health to develop a Hot Start approach for Ligase Chain Reaction (LCR). Hot Start LCR will employ chemically modified ligation components containing thermolabile protecting groups to eliminate common performance problems seen in LCR, such as false-positive signals and non-specificity.
In today's troubled economy, saving money is a hot topic. No matter what gets cut from your budget, however, experts at The University of Texas M. D. Anderson Cancer Center believe that healthy choices to prevent cancer shouldn't be on the list.
Safe, in-person school during the COVID-19 pandemic requires research that involves community engagement in underserved or vulnerable areas of the United States, writes Alison Cernich, Ph.D., deputy director of NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and colleagues.
› Verified 5 days ago
Dr. Linda Fong, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-3290 | |
Dr. Robert Peter Gale, Infectious Disease Medicare: Medicare Enrolled Practice Location: 11693 San Vicente Blvd, Suite 335, Los Angeles, CA 90049 Phone: 310-442-9010 | |
Dr. Tarek Alasil, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8616 La Tijera Blvd Ste 404, Los Angeles, CA 90045 Phone: 310-673-2020 Fax: 310-469-5290 | |
David Michael Tellalian, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8635 W 3rd St Ste 465w, Los Angeles, CA 90048 Phone: 310-358-2300 Fax: 310-358-2308 | |
Dr. Jan B King, M.D., M.P.H. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 11833 Wilmington Ave Fl 2, Los Angeles, CA 90059 Phone: 323-568-8701 | |
Dr. Caroline Hwang, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1520 San Pablo St, Suite 1000, Los Angeles, CA 90033 Phone: 323-442-5100 | |
Dr. Jennifer A Fulcher, M.D., PH.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 10833 Le Conte Ave, Chs 37-121, Los Angeles, CA 90095 Phone: 310-825-7225 |